These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies. Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432 [TBL] [Abstract][Full Text] [Related]
5. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction]. Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593 [No Abstract] [Full Text] [Related]
6. [Calcium antagonists in acute myocardial infarction]. Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992 [No Abstract] [Full Text] [Related]
7. Calcium channel blockers in the management of myocardial infarction patients. Gheorghiade M Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826 [No Abstract] [Full Text] [Related]
8. Current status of calcium channel blocking drugs after myocardial infarction. Moss AJ Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237 [TBL] [Abstract][Full Text] [Related]
9. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review. Moss AJ Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311 [TBL] [Abstract][Full Text] [Related]
10. [Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?]. Ennezat PV; Auffray JL; Darchis J; Rousselle M; Gonin X; Aubert JM; Bauchart JJ; Bauters C; Van Belle E; Asseman P Therapie; 2006; 61(3):191-4. PubMed ID: 16989118 [TBL] [Abstract][Full Text] [Related]
11. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats. Kaur AH; Singh M; Singh J; Jain K Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848 [No Abstract] [Full Text] [Related]
12. Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction. Schwartz A Am J Cardiol; 1982 Feb; 49(3):497-8. PubMed ID: 7058761 [No Abstract] [Full Text] [Related]
14. Calcium antagonists in the treatment early after myocardial infarction. The DEFIANT Research Group. Schartl M J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S79-81. PubMed ID: 1282620 [No Abstract] [Full Text] [Related]
15. Calcium channel blockers: an evidence-based review. Waters D Can J Cardiol; 1997 Aug; 13(8):757-66. PubMed ID: 9284842 [TBL] [Abstract][Full Text] [Related]
16. Calcium channel blockers and mortality in elderly patients with myocardial infarction. Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174 [TBL] [Abstract][Full Text] [Related]
17. Why Ca2+ antagonists will be most useful before or during early myocardial ischemia and not after infarction has been established. Danish Study Group on Verapamil in Myocardial Infarction. Hansen JF Eur Heart J; 1986 Oct; 7(10):910-1. PubMed ID: 3792353 [No Abstract] [Full Text] [Related]
18. Calcium channel blockers for heart rate control in atrial fibrillation complicated by congestive heart failure. Heywood JT Can J Cardiol; 1995 Oct; 11(9):823-6. PubMed ID: 7585281 [TBL] [Abstract][Full Text] [Related]
19. [Indications for calcium channel antagonist therapy according to the latest large clinical trials]. Kosicka T; Kara-Perz H; Głuszek J; Perz S Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496 [No Abstract] [Full Text] [Related]